[Study on the new development of highly sensitive E2-EIA used by two specific binding systems and on the clinical...

Area of Science:

• Endocrinology
• Biochemistry
• Assay Development

Background:

• Accurate quantification of 17-beta-estradiol (E2) is crucial for reproductive health monitoring.
• Existing methods for E2 measurement may have limitations in sensitivity or practicality.
• Development of novel, reliable immunoassays is essential for clinical and research applications.

Observation:

• A biotinylated tracer (E2-B) was synthesized by conjugating biotin to 6-ethylenediamino-17-beta-estradiol.
• Two competitive enzyme immunoassay (EIA) methods were established using the E2-B tracer.
• Method I involved mixing E2-B, sample, and HRP-conjugated anti-E2 antibody, followed by binding to avidin-coated microplates.
• Method II involved incubating samples with anti-E2 adsorbed microplates, followed by detection with HRP-conjugated avidin.

Findings:

• Method I quantified E2 in the range of 75 pg/ml to 9.6 ng/ml.
• Method II quantified E2 in the range of 75 pg/ml to 19.2 ng/ml.
• Both novel EIA methods demonstrated strong correlation with traditional 3H-Radioimmunoassay (RIA).

Implications:

• The developed EIAs offer sensitive and reliable quantification of E2.
• These assays are valuable tools for monitoring ovulation induction processes.
• The methods provide a viable alternative to existing E2 measurement techniques.